07/20/2026
This is a drug recall alert. The information is an excerpt from The Epoch Times.
A pharmaceutical company recalled thousands of bottles of a commonly used allergy drug nationwide due to a failed test of the drug’s purity, according to a notice published by the Food and Drug Administration (FDA) this week.
According to the FDA’s recall website, 9,048 bottles of fexofenadine hydrochloride tablets in 180-milligram dosages are under recall.
The bottles have 150 tablets each, the notice added.
The reason for the recall is due to “Failed Impurities/Degradation Specifications,” which may mean that the drug failed to maintain its integrity across its shelf life.
The company recalling the drug is Sun Pharmaceutical Industries, India’s largest drug company and one of the biggest generic drugmakers in the world.
The drugs were distributed by New Jersey-based Ohm Laboratories, Inc., according to the notice.
The impacted lots of recalled medication are lot DNG0283A with an expiration date of March 31, 2027; lot DNF0922A with an expiration of Oct. 31, 2026; and lot DNF0923B with an expiration of Oct. 31, 2026, the FDA notice said.